Anti-STK40 monoclonal antibody

Pre-made anti-STK40 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to STK40/STK40 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1841-Ab-1/ GM-Tg-hg-IP1841-Ab-2Anti-Human STK40 monoclonal antibodyHuman
GM-Tg-rg-IP1841-Ab-1/ GM-Tg-rg-IP1841-Ab-2Anti-Rat STK40 monoclonal antibodyRat
GM-Tg-mg-IP1841-Ab-1/ GM-Tg-mg-IP1841-Ab-2Anti-Mouse STK40 monoclonal antibodyMouse
GM-Tg-cynog-IP1841-Ab-1/ GM-Tg-cynog-IP1841-Ab-2Anti-Cynomolgus/ Rhesus macaque STK40 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1841-Ab-1/ GM-Tg-felg-IP1841-Ab-2Anti-Feline STK40 monoclonal antibodyFeline
GM-Tg-cang-IP1841-Ab-1/ GM-Tg-cang-IP1841-Ab-2Anti-Canine STK40 monoclonal antibodyCanine
GM-Tg-bovg-IP1841-Ab-1/ GM-Tg-bovg-IP1841-Ab-2Anti-Bovine STK40 monoclonal antibodyBovine
GM-Tg-equg-IP1841-Ab-1/ GM-Tg-equg-IP1841-Ab-2Anti-Equine STK40 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1841-Ab-1/ GM-Tg-hg-IP1841-Ab-2; GM-Tg-rg-IP1841-Ab-1/ GM-Tg-rg-IP1841-Ab-2;
GM-Tg-mg-IP1841-Ab-1/ GM-Tg-mg-IP1841-Ab-2; GM-Tg-cynog-IP1841-Ab-1/ GM-Tg-cynog-IP1841-Ab-2;
GM-Tg-felg-IP1841-Ab-1/ GM-Tg-felg-IP1841-Ab-2; GM-Tg-cang-IP1841-Ab-1/ GM-Tg-cang-IP1841-Ab-2;
GM-Tg-bovg-IP1841-Ab-1/ GM-Tg-bovg-IP1841-Ab-2; GM-Tg-equg-IP1841-Ab-1/ GM-Tg-equg-IP1841-Ab-2
Products NameAnti-STK40 monoclonal antibody
Formatmab
Target NameSTK40
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-STK40 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1841-Ag-1Recombinant multi-species STK40/ SHIK/ SgK495 protein


    Target information

    Target IDGM-IP1841
    Target NameSTK40
    Gene ID83931,74178,360230,713214,482475,101089124,515723,100054972
    Gene Symbol and Synonyms2310004N11Rik,Lyk4,RGD1307310,SgK495,SHIK,STK40
    Uniprot AccessionQ8N2I9,Q7TNL4,Q17QV9
    Uniprot Entry NameSTK40_HUMAN,STK40_RAT,STK40_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000196182
    Target ClassificationKinase

    The target: STK40, gene name: STK40, also named as SHIK, SgK495. Predicted to enable ATP binding activity; protein serine kinase activity; and protein serine/threonine kinase activity. Predicted to be involved in protein phosphorylation. Predicted to act upstream of or within several processes, including glycogen metabolic process; lung development; and respiratory system process. Located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.